| المؤلفون: |
Song, Hongwei1 (AUTHOR), Ren, Junling1,2 (AUTHOR), Yang, Le3 (AUTHOR), Sun, Hui1 (AUTHOR) Sunhui7045@sina.com, Yan, Guangli1 (AUTHOR), Han, Ying1 (AUTHOR), Wang, Xijun1,2,3 (AUTHOR) xijunw@sina.com |
| مستخلص: |
Shen Bai formula (SBF) is a proven effective traditional Chinese medicine for treating viral myocarditis (VMC) sequelae in clinic, and myocardial injury is the pathological basis of VMC sequelae. However, the pharmacological action and mechanism of SBF have not been systematically elucidated. In present research, the doxorubicin-induced myocardial injury rat model was used to evaluate the efficacy of SBF, and energy metabolism and metabolomics approaches were applied to elucidate the effects of SBF on myocardial injury. Through energy metabolism measurement system and UPLC-Q-TOF-MS/MS oriented blood metabolomics, directly reflected the therapeutic effect of SBF at a macro level, and identified biomarkers of myocardial injury in microcosmic, revealing its metabolomic mechanism. Results showed that SBF significantly improved the electrocardiogram (ECG), heart rate (HR), extent of myocardial tissue lesion, and ratio of heart and spleen. In addition, the serum levels of AST, CK, LDH, α-HBDH, cTnI, BNP, and MDA decreased, whereas SOD and ATP activity and content increased. Moreover, SBF increased locomotor activity and basic daily metabolism in rats with myocardial injury, restoring their usual level of energy metabolism. A total of 45 potential metabolomic biomarkers were identified. Among them, 44 biomarkers were significantly recalled by SBF, including representative biomarkers arachidonic acid (AA), 12-HETE, prostaglandin J 2 (PGJ 2), 15-deoxy-Δ-12,14-PGJ 2 , 15-keto-PGE 2 , 15(S)-HPETE, 15(S)-HETE, 8,11,14-eicosatrienoic acid and 9(S)-HODE, which involved AA metabolism, biosynthesis of unsaturated fatty acids and linoleic acid metabolism. We successfully replicated a myocardial injury rat model with the intraperitoneal injection of doxorubicin, and elucidated the mechanism of SBF in treating myocardial injury. This key mechanism may be achieved by targeting action on COX, Alox, CYP, and 15-PGDH to increase or decrease the level of myocardial injury biomarker, and then emphatically interven in AA metabolism, biosynthesis of unsaturated fatty acids and linoleic acid metabolism, and participate in regulating purine metabolism, sphingolipid metabolism, primary bile acid biosynthesis, and steroid hormone synthesis. [Display omitted] • Combine macro energy metabolism with micro serum metabolomics methods to systematically evaluate the efficacy of SBF. • Regulation of arachidonic acid and linoleic acid metabolism are the key pathways of SBF in treating myocardial injury. • COX, Alox, CYP, and 15-PGDH are the key enzymes in the treatment of myocardial injury with SBF. [ABSTRACT FROM AUTHOR] |
